Semaglutide, the drug behind Ozempic and Wegovy, may have benefits that extend well beyond weight loss and diabetes. In a large Swedish study of nearly 15,000 people with bipolar disorder, its use was linked to a 21% lower risk of psychiatric hospitalization. Researchers think effects on inflammation and brain-related biological pathways could help stabilize mood, though other GLP-1 drugs did not show the same association.
More in Research
Scientists discover a powerful new antivenom hidden in rattlesnake blood
September 8, 2026
Your personality may be more genetic than scientists realized
September 8, 2026
Giant new dinosaur discovered beneath construction site in Brazil
September 8, 2026
Scientists observe Einstein’s gravity in the quantum world for the first time
September 8, 2026
The American “cheetah” wasn’t a cheetah at all
September 8, 2026
Scientists find a new weakness in treatment-resistant prostate cancer
September 8, 2026
Latest News
Cotopaxi Coupon Codes: 60% Off in 2026
September 8, 2026
The Best Hotels in Berlin at Every Price Point
September 8, 2026
Bengaluru CEO reveals how hectic work schedule left him in ICU for 4 months: ‘Sunday was just a slower Monday’
September 8, 2026
On California's Central Coast, an Indoor-Outdoor Museum Connects Visitors With Centuries of Chumash Heritage
September 8, 2026
Earthquake hits Tibet again: Magnitude 5.3 this time at a depth of 35 km; Nepal feels tremor
September 8, 2026
Former Delhi chief secretary Rakesh Mehta dies by suicide at Noida residence
September 8, 2026